901 results on '"El-Serag, Hashem"'
Search Results
2. Proton Pump Inhibitors: Rational Use and Use-Reduction – The Windsor Workshop
3. RE.GA.IN.: the Real-world Gastritis Initiative–updating the updates
4. Genome-wide association study identifies high-impact susceptibility loci for HCC in North America
5. Serum biomarker signature is predictive of the risk of hepatocellular cancer in patients with cirrhosis
6. Evolving Concepts in Helicobacter pylori Management
7. Hepatocellular and extrahepatic cancer risk in people with non-alcoholic fatty liver disease
8. A Practical Guide to Evaluating and Using Big Data in Digestive Disease Research
9. Race/ethnicity and sex differences in the association between area-level arsenic exposure concentration and hepatocellular carcinoma (HCC) incidence rates in Texas. An ecological study
10. Risk Stratification Model for Hepatocellular Cancer in Patients With Cirrhosis
11. Management advice for patients with reflux-like symptoms: an evidence-based consensus
12. The Impact of Race on Pancreatic Cancer Treatment and Survival in the Nationwide Veterans Affairs Healthcare System
13. Concurrence of inflammatory bowel disease with multiple sclerosis or Hodgkin lymphoma
14. Bioimpedance analysis predicts the etiology of cirrhosis in a prospective cohort study
15. Contributors
16. Screening and Early Detection
17. Development and Validation of the Houston-BEST, a Barrett’s Esophagus Risk Prediction Model Adaptable to Electronic Health Records
18. Recent Decline in the Incidence of Hepatocellular Carcinoma in the United States
19. Diabetes Status and Pancreatic Cancer Survival in the Nationwide Veterans Affairs Healthcare System
20. Limits of the AGA Practice Update for Barrett’s Esophagus Screening: A Proposal for Electronic Health Record–Adaptable Risk Models
21. Association of Diet Quality with Metabolic (Dysfunction) Associated Fatty Liver Disease in Veterans in Primary Care
22. Reassessing BCLC stage at transplant to predict risk of mortality and HCC recurrence in HCC liver transplant recipients
23. Opportunities to address gaps in early detection and improve outcomes of liver cancer
24. Validation of a Pre-endoscopy Risk Score for Predicting the Presence of Gastric Intestinal Metaplasia in a U.S. Population
25. The Prevalence and Determinants of NAFLD and MAFLD and Their Severity in the VA Primary Care Setting
26. Neighborhood-Level Factors Contribute to Disparities in Hepatocellular Carcinoma Incidence in Texas
27. Using Natural Language Processing to Automatically Identify Dysplasia in Pathology Reports for Patients With Barrett’s Esophagus
28. Data from A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women
29. Data from A Novel Biomarker Panel for the Early Detection and Risk Assessment of Hepatocellular Carcinoma in Patients with Cirrhosis
30. Supplementary Tables from A Novel Biomarker Panel for the Early Detection and Risk Assessment of Hepatocellular Carcinoma in Patients with Cirrhosis
31. Supplementary Figure 3 from A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women
32. Supplementary Figure Legends from A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women
33. Supplementary Figure 2 from A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women
34. The Association between Caffeine Intake and the Colonic Mucosa-Associated Gut Microbiota in Humans—A Preliminary Investigation
35. Supplementary Table 1 from A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women
36. Supplementary Tables from A Novel Biomarker Panel for the Early Detection and Risk Assessment of Hepatocellular Carcinoma in Patients with Cirrhosis
37. Supplementary Figure 1 from A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women
38. Supplementary Material from A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women
39. Supplementary Figure 3 from A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women
40. Supplementary Material from A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women
41. Supplementary Figure 2 from A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women
42. Data from A Novel Biomarker Panel for the Early Detection and Risk Assessment of Hepatocellular Carcinoma in Patients with Cirrhosis
43. Data from A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women
44. Supplementary Figure Legends from A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women
45. Supplementary Figure 1 from A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women
46. Supplementary Table 1 from A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women
47. Admixture Mapping in African Americans Identifies New Risk Loci for HCV-Related Cirrhosis
48. Prevention of Hepatocellular Carcinoma (HCC). White Paper of the Texas Collaborative Center for Hepatocellular Cancer (TeCH) Multi-stakeholder Conference
49. Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention
50. Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.